Your browser doesn't support javascript.
loading
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.
Ejlertsen, B; Aldridge, J; Nielsen, K V; Regan, M M; Henriksen, K L; Lykkesfeldt, A E; Müller, S; Gelber, R D; Price, K N; Rasmussen, B B; Viale, G; Mouridsen, H.
Afiliação
  • Ejlertsen B; Danish Breast Cancer Cooperative Group Statistical Center; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: ejlertsen@rh.dk.
  • Aldridge J; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA.
  • Nielsen KV; Dako A/S, Glostrup, Denmark.
  • Regan MM; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA; Department of Biostatistics, Harvard School of Public Health; Department of Medicine, Harvard Medical School, Boston, USA.
  • Henriksen KL; Department of Breast Cancer Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.
  • Lykkesfeldt AE; Department of Breast Cancer Research, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.
  • Müller S; Dako A/S, Glostrup, Denmark.
  • Gelber RD; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA; Department of Biostatistics, Harvard School of Public Health; Department of Medicine, Harvard Medical School, Boston, USA; International Breas
  • Price KN; International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA; International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, USA.
  • Rasmussen BB; Department of Pathology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Viale G; Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Pathology Review Office, European Institute of Oncology, University of Milan, Milan, Italy.
  • Mouridsen H; Danish Breast Cancer Cooperative Group Statistical Center; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ann Oncol ; 23(5): 1138-1144, 2012 May.
Article em En | MEDLINE | ID: mdl-21986093
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma / Antineoplásicos Hormonais / Receptor alfa de Estrogênio Tipo de estudo: Clinical_trials / Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma / Antineoplásicos Hormonais / Receptor alfa de Estrogênio Tipo de estudo: Clinical_trials / Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article